Navigation Links
VIVUS Reports Third Quarter 2009 Highlights and Financial Results
Date:11/3/2009

25,477 41,392 73,434 Operating expenses: Cost of goods sold and manufacturing 2,609 2,547 8,089 8,263 Research and development 17,174 15,590 57,501 54,296 Selling, general and administrative 5,008 4,502 14,974 13,099 ----- ----- ------ ------ Total operating expenses 24,791 22,639 80,564 75,658 ------ ------ ------ ------ Income (loss) from operations (20,356) 2,838 (39,172) (2,224) Interest (expense) income, net of other-than-temporary loss on impaired securities (707) (2,567) (1,898) (1,008) ---- ------ ------ ------ Income (loss) before provision for income taxes (21,063) 271 (41,070) (3,232) Provision for income taxes (3) (5) (9) (15) -- -- -- --- Net income (loss) $(21,066) $266 $(41,079) $(3,247) ======== ==== ======== ======= Net income (loss) per share: Basic and diluted $(0.30) $0.00 $(0.59) $(0.05) Shares used in per share computation: Basic 70,942 66,122 70,149 61,801 Diluted 70,942 67,784 70,149 61,801 VIVUS, Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except par value amount)
'/>"/>
SOURCE VIVUS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. VIVUS Reports First Quarter 2009 Financial Results and Highlights
2. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
3. VIVUS to Present at the Needham and Company Life Sciences Conference
4. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
5. VIVUS to Present at Four Upcoming Healthcare Conferences
6. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...wire-FirstCall/ -- BioMarin Pharmaceutical Inc. (N...rug Administration (FDA) has granted orphan drug d...ampridine phosphate, for the rare autoimmune disea...DAP has previously received orphan drug designatio...e for Medicinal Products for Human Use of the Euro...
(Date:11/30/2009)...Newswire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a...l-device research and,development outsourcing comp...,announced that it had been selected to the Deloi...th consecutive year. The list recognizes the 50,fa...ia, and telecommunications,industries based on rev...
(Date:11/28/2009)...onal Advisory Committee on Climate Change (NACCC) ...oject in collaboration with the Vanuatu Meteorolog...have generated preliminary climate change and sea ...or the country’s SNC reporting to the United...NFCCC). , Port Vila, Van...
(Date:11/26/2009)...ion of ultrasmall transistors and more powerful co...ucting nanowires are closer to reality after a key...y and the University of California at Los Angeles....nowires with layers of different materials that ar...critical requirement for making efficient transist...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3
...edical,Technologies, Inc. (Nasdaq: VNUS ), a lead...invasive treatment of peripheral vascular disease,...ial results for the third,quarter ended September ..., VNUS plans to host its regular quarterly teleco... 29. This call will be webcast live for all,invest...
..., NAPA, Calif., Oct. 13 Senetek PLC (OTC,Bulleti...n the development,of technologies that target the ... company continues to maintain a strong, debt-free...excess of $16 Million; $10 Million,of which is inv...eposits,and $6 Million on deposit in a money marke...
...USSELS, October 13 The International Diabetes,Fed...together key opinion,leaders to push for action to...abetes in developing countries without access to c...edicines for Children in the,Developing World, wil...d,Kingdom. The International Diabetes Federation h...
Other Biology Technology:VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29 2Senetek Affirms Strong Financial Position 2Senetek Affirms Strong Financial Position 3International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 2International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 3
(Date:11/26/2009)...ried out in eight European countries has shown tha...sease pandemic could have a significant role in re...n the open access journal BMC Infectious Diseases...ays and weekends/holidays, finding that they were ... Hasselt and Antwerp University, Belgium, led a te...
(Date:11/26/2009)...illin-resistant Staphylococcus Aureus ) and other...s low-temperature plasma prototype devices have be...ing bactericidal cocktails. , Two prototype devi...ction of healthy skin (e.g. hands and feet) in hos... lethal threat; and another to shoot bacteria-kill...
(Date:11/25/2009)... Bacteria don,t have easy lives. In addition to ma... have natural enemies called bacteriophages, virus...days. , Still, bacteria and another class of mi...xtreme environments such as deep-sea volcanic vent...ey have a built-in defense system that helps prote...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Nile Therapeutics Reports 2009 Second Quarter Financial Results 54421 1Nile Therapeutics Reports 2009 Second Quarter Financial Results 54421 2Nile Therapeutics Reports 2009 Second Quarter Financial Results 54421 3Nile Therapeutics Reports 2009 Second Quarter Financial Results 54421 4Birner Dental Management Services Inc Announces Earnings Per Share Up 33 25 for 2nd Quarter 2009 54418 1Birner Dental Management Services Inc Announces Earnings Per Share Up 33 25 for 2nd Quarter 2009 54418 2Birner Dental Management Services Inc Announces Earnings Per Share Up 33 25 for 2nd Quarter 2009 54418 3Birner Dental Management Services Inc Announces Earnings Per Share Up 33 25 for 2nd Quarter 2009 54418 4Birner Dental Management Services Inc Announces Earnings Per Share Up 33 25 for 2nd Quarter 2009 54418 5Birner Dental Management Services Inc Announces Earnings Per Share Up 33 25 for 2nd Quarter 2009 54418 6Birner Dental Management Services Inc Announces Earnings Per Share Up 33 25 for 2nd Quarter 2009 54418 7Birner Dental Management Services Inc Announces Earnings Per Share Up 33 25 for 2nd Quarter 2009 54418 8Birner Dental Management Services Inc Announces Earnings Per Share Up 33 25 for 2nd Quarter 2009 54418 9Birner Dental Management Services Inc Announces Earnings Per Share Up 33 25 for 2nd Quarter 2009 54418 10Boozing Blunts Ability to Read Faces 54415 1Boozing Blunts Ability to Read Faces 54415 2
...onal Institute of Allergy and Infectious Diseases ... Health, have discovered a survival mechanism in a...he mechanism lets the bacteria protect itself by w...Ps), which are defense molecules sent by the body ...types, gram-positive and gram-negative, with the p...
...ain different gene mutations, but just how these m...been a mystery. , A new clue comes from scientists...l Schools of Medicine and Public Health. Their res... birth to 20 years old, may specifically increase ...different mutation, on the NRAS gene, was found in...
... shown a significant increase in Northern Ireland ...t men, older people and those living in more afflu...the June issue of British Journal of Dermatology. ...tics for nearly 23,000 patients over a 12-year per...nd a 62 per cent increase in skin cancer samples p...
Other Biology News:Newly found sensing system enables certain bacteria to resist human immune defenses 2Sun exposure early in life linked to specific skin cancer gene mutation 2Rising skin cancer rates are more likely to affect wealthy people, says 12-year review 2Rising skin cancer rates are more likely to affect wealthy people, says 12-year review 3
...lized White solid. PACKAGED UNDER INERT GAS. DO ...ide resin with applications similar to those of DT...5 ) but with the important advantage that no solub...™ Reagent can be used in a batch technique, ...
Cleland’s Reagent, Molecular Biology Grade from Calbiochem
...pan, also named Sendai virus) Envelope VECTOR KIT ...f membrane fusion. Most efficient transfection are...s, Vector, and Biomolecule in vitro and in vivo. ...ort period of time that benetif sensitive primary ...
Cleland’s Reagent, ULTROL® Grade from Calbiochem
Biology Products: